OCS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Oculis Holding AG Ordinary shares · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 11.31 USD
1.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -50.1% below the Trend Line and sits at 3.3% of its 52-week range. The latest completed week returned 1.6%, after a -19.9% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 25/100 conviction, while the latest news-sentiment score is 52/100. Near-term considerations: volume confirmation is below normal; earnings are due in 4d.

Setup score 20 out of 100
Latest Close 11.31 USD 31 Jul 2026
1W Return 1.6% latest completed week
4W Return -19.9% short-term follow-through
12W Return -65.3% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.6% Latest completed week; four-week move -19.9%. Indicator stack 35/26 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Mixed 25/100 conviction; expected move 26.5%. News sentiment 52/100 56 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -50.1% below the Trend Line and sits at 3.3% of its 52-week range. The latest completed week returned 1.6%, after a -19.9% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1412-week average 0.47

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.14Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers

No recent accumulation markers. 6 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -19.9% over four weeks, -65.3% over 12 weeks, and -36.1% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.6%
4W-19.9%
12W-65.3%
26W-60.2%
52W-36.1%
Active trend streak0 weeks
Active weeks in one year33
Trend breadth63.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.32Latest activity-pressure read.
Pressure change-2.3%Four-week change in activity pressure.
Leadership-51.45Latest relative-leadership reading.
RS change-18.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength47/100Blend of value, momentum, and quality. Underlying universe rank 54; rank 1 is best.
Value48/100Relative valuation strength. Underlying universe rank 53; rank 1 is best.
Quality47/100Profitability and accounting quality. Underlying universe rank 54; rank 1 is best.
Momentum48/100Medium-term price momentum. Underlying universe rank 53; rank 1 is best.
Growth48/100Revenue and earnings growth. Underlying universe rank 53; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1333.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-10.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-18285.4%
Operating profit retained from revenue.
Free-cash-flow margin
-12417.0%
Free cash flow generated from revenue.
Return on invested capital
-51.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
105.7%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
-16.5%
Net share repurchases relative to market value.
Shareholder yield
-16.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

OCS shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 26.5%, and Sharemaestro trend signal inactive.

Conviction25/100
Expected move26.5%
Put/call volume
Pressure11
Speculation0
Volatility95
Trend agreement44
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment52/100

Weighted news tone is neutral across 56 relevant articles.

8 positive · 42 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move26.5%Nearest-chain priced movement where available.
52-week drawdown-67.2%Distance below the 52-week high.
13-week volatility17.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+18.8%Week of 8 May.
Worst week-50.6%Week of 5 Jun.
Latest week+1.6%Week of 31 Jul.

Shape of recent returns

Strong gains4
Modest gains9
Flat weeks0
Modest losses6
Sharp losses7
Recent vol17.1%13-week weekly-return volatility.
Base vol10.4%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew6.2% / -6.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape25/100

Trend, activity pressure, participation, and risk combine to a 25/100 tape read.

 Indicator analysis17/100

Latest 12-week confirmation: trend 3/12, activity pressure 3/12, relative leadership 2/12.

Activity pressure 0.14; 6 reversal markers Factors46/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 89; Small Cap Core rank 55 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options41/100

OCS shows mixed options pressure with a 25/100 conviction score, put-call volume ratio of n/a, expected move of 26.5%, and Sharemaestro trend signal inactive.

Mixed · Options-market disagreement · Expected move 26.5% Sentiment52/100

Weighted news tone is neutral across 56 relevant articles.

OCS|Oculis Holding AG|Price:11.230|Chg%:+0.390 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202611.31 USD1.6%22.66 USD16.67 USD-1.32-51.451.7MOff
24 Jul 202611.13 USD-8.7%22.95 USD16.68 USD-1.34-52.381.5MOff
17 Jul 202612.19 USD-10.6%23.26 USD16.69 USD-1.33-49.111.5MOff
10 Jul 202613.63 USD-3.5%23.56 USD16.69 USD-1.32-45.882.1MOff
3 Jul 202614.12 USD17.7%23.80 USD16.68 USD-1.29-43.362.1MOff
26 Jun 202612.00 USD7.0%24.05 USD16.67 USD-1.19-51.832.6MOff
19 Jun 202611.22 USD1.2%24.28 USD16.68 USD-1.00-57.422.7MOff
12 Jun 202611.09 USD-1.1%24.55 USD16.68 USD-0.64-57.284.4MOff
5 Jun 202611.21 USD-50.6%24.83 USD16.69 USD-0.30-56.3113.7MOff
29 May 202622.70 USD-23.0%25.10 USD16.69 USD0.02-16.463.7MOn
22 May 202629.49 USD-2.6%24.99 USD16.62 USD0.0911.242.6MOn
15 May 202630.29 USD-7.2%24.71 USD16.50 USD0.0415.872.4MOn
8 May 202632.64 USD18.8%24.43 USD16.39 USD-0.0925.002.0MOn
1 May 202627.48 USD3.9%24.04 USD16.25 USD-0.2611.482.5MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.